Quidel Stock Price

-0.78 (-0.29%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Quidel Corp QDEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.78 -0.29% 268.00 19:59:33
Close Price Low Price High Price Open Price Previous Close
268.29 255.00 275.55 255.01 268.78
Bid Price Ask Price Spread News
266.90 268.99 2.09 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
16,488 1,006,808 $ 266.14 $ 267,955,858 968,880 55.42 - 324.25
Last Trade Time Type Quantity Stock Price Currency
19:59:33 3 $ 267.00 USD

Quidel Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 11.24B 41.95M 37.48M $ 534.89M $ 140.14M 1.72 76.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Quidel News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QDEL Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week245.26275.55235.84265.23690,79722.749.27%
1 Month221.67287.30221.07262.01784,42246.3320.9%
3 Months287.28292.95135.02204.211,256,617-19.28-6.71%
6 Months138.18324.25134.31204.961,194,387129.8293.95%
1 Year61.01324.2555.42176.71795,014206.99339.27%
3 Years42.43324.2533.01128.49450,971225.57531.63%
5 Years20.46324.2513.2105105.76349,600247.541,209.87%

Quidel Description

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.